On 14 December 2025, 𝐌𝐬. 𝐄𝐥𝐚𝐢𝐧𝐞 𝐖𝐨𝐧𝐠, 𝐂𝐨-𝐟𝐨𝐮𝐧𝐝𝐞𝐫 & 𝐂𝐄𝐎 𝐨𝐟 𝐘-𝐋𝐎𝐓, was invited to the PolyU–Wuxi Technology and Innovation Research Institute for a formal inspection and exchange visit. During the visit, Ms. Wong met with officials of the Wuxi Municipal Government, including Ms. Yaofang Ji, Deputy Director of the Wuxi Airport Economic Development Zone Management Committee, and Mr. Chen Cao, CEO of AIM Pharmaceutical International Ltd. The discussions provided an in‑depth, on‑site understanding of the latest progress of AIM Pharma’s “Oxyphylla A” therapeutic project, which has officially landed in Wuxi and commenced operations.
The “Oxyphylla A” project is one of the flagship initiatives supported under Hong Kong’s “RAISe+” Programme, with Wuxi as its operational base. The project team joined the 𝐘-𝐋𝐎𝐓 “Wuxi–HK SciTech Exchange Tour” in April 2025 for substantive dialogue, subsequently signing the agreement and completing SciTech project landing in August 2025. This visit was a follow‑up to review the project’s implementation and early development after establishment.
From facilitating the landing of the pioneering Atomic Semiconductor Project to continuously supporting the advancement of the Oxyphylla A initiative by 𝐌𝐬. 𝐄𝐥𝐚𝐢𝐧𝐞 𝐖𝐨𝐧𝐠, 𝐘-𝐋𝐎𝐓 has remained steadfast in its role as a strategic bridge, enabling high‑potential SciTech projects to achieve industrial transformation in Wuxi. Through pragmatic collaboration, 𝐘-𝐋𝐎𝐓 continues to champion the development model of “incubating in Hong Kong, producing in Wuxi,” fostering deeper cross‑regional innovation synergy and accelerating the commercialisation of scientific research achievements.
12月14日，𝐘-𝐋𝐎𝐓聯合創始人兼行政總裁王靜嫻女士受邀前往香港理工大學無錫科技創新研究院進行考察交流。在考察中，王靜嫻女士與智仁藥業國際有限公司行政總裁曹晨、無錫空港經開區管委會副主任季要芳等領導，一同實地了解了已落地無錫的智仁藥業「神經營養素項目」的最新進展。
智仁藥業「神經營養素項目」是獲得香港「產學研1+計劃」資助並落戶無錫的重點項目之一。項目團隊曾於今年4月參與「𝐘-𝐋𝐎𝐓錫港科創交流團」進行深入對接，並最終於8月成功簽約落戶。此次考察旨在對項目落地後的推進情況進行實地跟進。
從王靜嫻女士推動首個項目「原子半導體」落地，到持續跟進「神經營養素」項目，𝐘-𝐋𝐎𝐓始終積極發揮橋樑作用，協助具有潛力的創科項目在無錫實現產業轉化，務實推動「孵在香港，產在無錫」的發展路徑。
